August 26, 2022 CFSI Staff

Drug residue in shrimp imports a focus of FDA AI program

A U.S. Food and Drug Administration pilot program is using artificial intelligence to screen for shrimp imports contaminated by antibiotics.

The FDA recently kicked off the third phase of its artificial intelligence (AI) imported seafood pilot program, which uses AI and machine learning to strengthen its import screening process and to ensure foods entering the U.S are safe.

“We have begun to focus on areas of increased risk, such as shrimp contaminated by aquaculture drugs, for foreign inspections. This includes increased importer inspections, higher rates of sampling and examination, and use of non-traditional tools, such as third-party audits, specific to this commodity,” the FDA said in a Constituent Update

Read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Skip to content